B-K releases scanners, transducers
The Denmark-based subsidiary of Analogic, B-K Medical, exhibited several new ultrasound technologies at the American College of Surgeons Annual Clinical Congress in October. Topping the introductions were the Hawk 2102 EXL color scanner, the company's
The Denmark-based subsidiary of Analogic, B-K Medical, exhibited several new ultrasound technologies at the American College of Surgeons Annual Clinical Congress in October. Topping the introductions were the Hawk 2102 EXL color scanner, the company's new flagship ultrasound scanner, and the new black-and-white Falcon 2101 EXL. Both incorporate advanced focusing and proprietary detector technology, large monitors, sophisticated video interface, and fully integrated 3D option. The Hawk also boasts improved Doppler functionality. Vascular scanning is enhanced by a new, dedicated transducer, dubbed type 8812, which combines deep Doppler sensitivity with near-field performance. The company also showed a new transducer optimized for breast and musculoskeletal scanning. The probe, which works with B-K's portable Merlin 1101, is pending FDA clearance for musculoskeletal applications.
Two weeks after the conference, the company announced the resignation of Rene Barington as its managing director. Barington held the post for six years.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 5th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 5th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
August 5th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
